FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $342,507 | -43.4% | 161,560 | +27.1% | 0.00% | – |
Q2 2023 | $605,139 | +4.3% | 127,130 | +24.9% | 0.00% | – |
Q1 2023 | $580,260 | -80.9% | 101,800 | -66.3% | 0.00% | -100.0% |
Q4 2022 | $3,045,162 | +33.5% | 301,800 | +196.5% | 0.00% | 0.0% |
Q3 2022 | $2,281,000 | -35.1% | 101,800 | -28.2% | 0.00% | -50.0% |
Q2 2022 | $3,514,000 | -36.1% | 141,790 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $5,503,000 | -33.6% | 141,947 | +0.3% | 0.00% | -33.3% |
Q4 2021 | $8,284,000 | -1.3% | 141,590 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $8,392,000 | -32.0% | 141,590 | -0.4% | 0.00% | -40.0% |
Q2 2021 | $12,341,000 | +15.9% | 142,190 | +10.1% | 0.01% | 0.0% |
Q1 2021 | $10,650,000 | +18.1% | 129,170 | +30.2% | 0.01% | +25.0% |
Q4 2020 | $9,020,000 | +146.9% | 99,200 | +8.5% | 0.00% | +100.0% |
Q3 2020 | $3,653,000 | +24.1% | 91,400 | +6.5% | 0.00% | 0.0% |
Q2 2020 | $2,944,000 | +64.3% | 85,800 | +6.3% | 0.00% | +100.0% |
Q1 2020 | $1,792,000 | +28.5% | 80,700 | +13.2% | 0.00% | 0.0% |
Q4 2019 | $1,395,000 | +31.1% | 71,300 | +4.1% | 0.00% | 0.0% |
Q3 2019 | $1,064,000 | -23.5% | 68,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,391,000 | +32.4% | 68,500 | +14.5% | 0.00% | 0.0% |
Q1 2019 | $1,051,000 | +42.0% | 59,800 | +3.6% | 0.00% | 0.0% |
Q4 2018 | $740,000 | +6.6% | 57,700 | +35.4% | 0.00% | – |
Q3 2018 | $694,000 | +121.7% | 42,600 | +54.3% | 0.00% | – |
Q2 2018 | $313,000 | +192.5% | 27,600 | +150.9% | 0.00% | – |
Q1 2018 | $107,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |